Andrew L. Ross is Director of iSpecimen Inc.. Currently has a direct ownership of 1.33 Million shares of ISPC, which is worth approximately $3.79 Million. The most recent transaction as insider was on Jan 01, 2023, when has been sold 125 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.33M
0% 3M change
0% 12M change
Total Value Held $3.79 Million

Andrew L. Ross Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 01 2023
BUY
Grant, award, or other acquisition
-
125 Added 0.01%
1,326,340 Common Stock
Nov 15 2021
BUY
Open market or private purchase
$5,300 $5.3 p/Share
1,000 Added 0.08%
1,313,524 Common Stock
Nov 10 2021
BUY
Open market or private purchase
$2,925 $5.85 p/Share
500 Added 0.04%
1,312,524 Common Stock
Jun 23 2021
BUY
Open market or private purchase
$2,608 $6.52 p/Share
400 Added 0.03%
1,311,024 Common Stock
Jun 21 2021
BUY
Conversion of derivative security
-
932,198 Added 41.83%
1,296,539 Common Stock
Jun 17 2021
BUY
Open market or private purchase
$627 $6.27 p/Share
100 Added 0.01%
1,310,624 Common Stock
ALR

Andrew L. Ross

Director
Lexington, MA

Track Institutional and Insider Activities on ISPC

Follow iSpecimen Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ISPC shares.

Notify only if

Insider Trading

Get notified when an I Specimen Inc. insider buys or sells ISPC shares.

Notify only if

News

Receive news related to iSpecimen Inc.

Track Activities on ISPC